AI-generated summary
In this mouse study, the authors examined whether 660 nm laser therapy changes gene expression of anti-apoptotic factors in lung neutrophils during lipopolysaccharide-induced lung inflammation. They report that laser treatment, like an NF-kappaB inhibitor, reduced Bcl-xL and A1 mRNA levels, and they suggest NF-kappaB may be involved. The study measured mRNA levels only in mice.
- Who or what was studied
- Mice with lipopolysaccharide-induced lung inflammation, divided into 8 groups of 7 animals each
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice and measured mRNA levels only, without a stated total sample size or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.